Navigation Links
March of Dimes awards $250,000 prize to 2 scientists who pioneered advances in skin disorders
Date:4/29/2012

WHITE PLAINS, NY April 30, 2012 Two scientists who have revolutionized the understanding of skin biology, creating crucial advances in treating skin cancers and other diseases as well as severe burns, have been chosen to receive the 2012 March of Dimes Prize in Developmental Biology.

Howard Green, MD, George Higginson Professor of Cell Biology, Department of Cell Biology, Harvard Medical School, and Elaine Fuchs, PhD, Rebecca C. Lancefield Professor, Laboratory of Mammalian Cell Biology & Development, Howard Hughes Medical Investigator, Rockefeller University, will share this year's prize.

Their work pioneered innovative technologies that explain the molecular underpinnigns of skin stem cells and inherited skin disorders, including cancers and some birth defects.

"Taken together, the research of Dr. Green and Dr. Fuchs has expanded medicine's ability to diagnose and understand the basis of many skin disorders, from cancer to inherited disorders to severe burns," said Joseph Leigh Simpson, MD, senior vice president for Research and Global Programs at the March of Dimes. "Their work has saved the lives of thousands of burn patients and we hope their work with skin stem cells will lead to new ways to prevent and treat birth defects."

Dr. Green and Dr. Fuchs have worked closely together. Dr. Fuchs is a former postdoctoral fellow in Dr. Green's lab, and throughout their careers they shared their scientific findings. Many of their findings have been translated into specific treatments.

Dr. Fuchs uncovered the genetic basis of blistering skin diseases and deciphered the characteristics of skin stem cells that allow them to develop into distinct tissues and organs. She also pioneered the use of reverse genetics, which studies protein functions and then determines what diseases occur when the proteins malfunction. She studies how skin stem cells become activated to form hair and skin, how they adapt to heal wounds, and h
'/>"/>

Contact: Elizabeth Lynch
elynch@marchofdimes.com
914-997-4286
March of Dimes Foundation
Source:Eurekalert

Page: 1 2 3

Related biology news :

1. Far-reaching genetics topics to be addressed: 2009 Annual Clinical Genetics Meeting, March 25-29
2. March launch planned for ESAs gravity mission
3. March of Dimes provides $2.7 million in new funding for preterm birth research
4. Penguins marching into trouble
5. Public Policy Center hosts flood symposium March 10-12
6. BioScience tip sheet, March 2009
7. Story tips from the Departments of Energys Oak Ridge National Lab -- March 2009
8. News from the March 2009 Journal of the American Dietetic Association
9. Prominent climate researcher to speak at UH on global warming March 5
10. AGU journal highlights -- March 12, 2009
11. Science returns to the Capitol Hill spotlight at March 24 exhibition
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/5/2015)... NXT-ID, Inc. (NASDAQ: NXTD ... company focused on the growing mobile commerce market, announces ... CEO Conference on January 29 th at 10:30 ... CEO of NXT-ID will present and host a live ... wallet and its full suite of biometric technologies. Investors ...
(Date:1/22/2015)... , Jan. 9, 2015 Valid S.A. ("Company") (BM&FBOVESPA: ... market in general the State of Washington,s ... for a new enrollment and central issuance system for driver,s ... The project planning and development will start in ...
(Date:1/22/2015)... 2015  A man-made form of insulin delivered by nasal ... in adults with mild cognitive impairment and Alzheimer,s disease ... at Wake Forest Baptist Medical Center. The ... cognitive impairment (MCI) or mild to moderate Alzheimer,s dementia ...
Breaking Biology News(10 mins):CEO of NXT-ID, Inc. to Discuss Company's Biometric Technologies at RedChip Online Conference January 29th 2CEO of NXT-ID, Inc. to Discuss Company's Biometric Technologies at RedChip Online Conference January 29th 3Valid USA Signs Contract For Washington Driver's License Issuance 2Nasal Spray with Insulin Equivalent Shows Promise as Treatment for Adults with Mild Cognitive Impairment, Alzheimer's Dementia 2Nasal Spray with Insulin Equivalent Shows Promise as Treatment for Adults with Mild Cognitive Impairment, Alzheimer's Dementia 3
... Singh Malik, Ph.D., of Fred Hutchinson Cancer Research Center, ... Institute to study the potential role of "genetic conflicts" ... Malik and colleagues want to find out whether a ... to determine whether autoimmunity when the body,s immune ...
... , ,A Griffith University PhD candidate has been highly awarded ... atom. Ben Norton, from the Kielpinski group in ... CiSRA Extreme Imaging Competition following extensive work on high resolution ... Inc.,s Australian research centre, the Extreme Imaging competition aims to ...
... is available in French . Vancouver, B.C. -- ... place at the wrong time. As a result of changing conditions, marine ... as three kilometres per year over the past 50 years, and forecasts ... years. Decisions on where to put MPAs weren,t always made with ...
Cached Biology News:Did an evolutionary arms race cause lupus? Biologist Harmit Malik receives grant to try and find out 2Extreme imaging wins science praise 2Marine protected areas: changing climate could require change of plans 2
(Date:2/27/2015)... BOSTON , Feb. 27, 2015   PureTech ... identifying, inventing and commercializing disruptive products and technologies in ... Christopher Viehbacher , former CEO and Member of the ... Directors.  "It,s has been a pleasure ... very excited that we will be working together more ...
(Date:2/26/2015)... WOODBRIDGE, N.J. , Feb. 26, 2015 ... and its affiliated companies, Wilentz, Goldman & ... a trade secrets lawsuit against Genewiz Inc. in excess ... obtained and utilized GenScript,s trade secrets, and that it ... court entered an order denying motions for judgment notwithstanding ...
(Date:2/26/2015)... SQI Diagnostics Inc. ("SQI" or the "Company") (TSX-V: SQD; ... commercializes proprietary technologies and products for advanced microarray diagnostics, ... fiscal first quarter ended December  31, 2014. All figures ... unless otherwise stated. "During the quarter ... existing customers and add to our sales pipeline," said ...
(Date:2/26/2015)... Calif. , Feb. 26, 2015   Regulus ... biopharmaceutical company leading the discovery and development of innovative ... Xanthopoulos , Ph.D., President and Chief Executive Officer of ... and Company 35 th Annual Healthcare Conference on ... conference is being held at the Boston Marriott Copley ...
Breaking Biology Technology:Christopher Viehbacher, former CEO of Sanofi, Joins PureTech's Board of Directors 2Christopher Viehbacher, former CEO of Sanofi, Joins PureTech's Board of Directors 3Christopher Viehbacher, former CEO of Sanofi, Joins PureTech's Board of Directors 4Wilentz Client GenScript Awarded $10 Million in Trade Secrets Case Against Genewiz 2Wilentz Client GenScript Awarded $10 Million in Trade Secrets Case Against Genewiz 3SQI Diagnostics Reports First Quarter Financial Results 2SQI Diagnostics Reports First Quarter Financial Results 3SQI Diagnostics Reports First Quarter Financial Results 4SQI Diagnostics Reports First Quarter Financial Results 5SQI Diagnostics Reports First Quarter Financial Results 6Regulus to Present at Cowen and Company 35th Annual Healthcare Conference 2Regulus to Present at Cowen and Company 35th Annual Healthcare Conference 3
... LLC of Irvine, California today announced a strategic ... CompanDX have forged a unique partnership to offer ... molecular diagnostic tests for clients in the healthcare ... deliver small composite biomarker signatures from complex data ...
... BOTHELL, Wash., June 16, 2011 SCOLR Pharma, Inc. ... sale of $1 million principal amount of its 8% ... an initial closing of its private offering of up ... may offer additional Debentures, up to the aggregate maximum ...
... , -- " Ask,Extractor ... " Help Researchers Narrow Search Results,-- ... information products and services, today announced two new,applications from Molecular ... Ask Extractor is an application based on Molecular ...
Cached Biology Technology:ResearchDx and CompanDX Announce Strategic Partnership 2SCOLR Pharma, Inc. Announces Initial Closing of Private Placement 2SCOLR Pharma, Inc. Announces Initial Closing of Private Placement 3Elsevier and Molecular Connections Develop Two New Applications on SciVerse Applications 2Elsevier and Molecular Connections Develop Two New Applications on SciVerse Applications 3Elsevier and Molecular Connections Develop Two New Applications on SciVerse Applications 4Elsevier and Molecular Connections Develop Two New Applications on SciVerse Applications 5Elsevier and Molecular Connections Develop Two New Applications on SciVerse Applications 6
Recommend to use at up to 5000X dilutions for cell culture (e.g. Add 1 ul to 1 ml of culture medium.)...
Prepared in distilled water....
... Weight Markers, 37 kBq, 1 uCi. Carbon-14 ... of the sample on Western blots.The Rainbow-labeled ... migration in the gel and on the ... without Rainbow-labeling is 0.37-3.7 MBq/mg (10-100 uCi/mg) ...
in vitro Translation, Accessory Products...
Biology Products: